Takeda's Director of Obesity Marketing Katie Andino told MM&M in a phone interview that the drugmaker will be taking a unique approach to courting all three parties. Although Andino could not discuss specifics until Contrave (naltrexone and bupropion) hits the marketplace, the brand already has experience with speaking to consumers differently, as seen by the tone and all-out approach Orexigen used when recruiting patients for its clinical trials.
In terms of commercial outreach, Andino said Takeda will be focusing on patients “who are ready to go on Contrave, [and] are in the right frame of mind” to pair a chronic medication with lifestyle changes that include an activity regimen and diet modification. These same add-ons are essential components for success with Belviq and Qsymia, but Takeda indicates its approach will add a new voice to the weight-loss conversation.
The professional push will include samples, speakers and 900 Takeda sales representatives, some of whom will be making only Contrave-focused visits, while others will be able to talk about Contrave as well as Takeda's diabetes medications. Because of the overlap between diabetes and obese patients—obesity can put patients at risk for diabetes—the firm has an opportunity to build on relationships they already have with physicians such as endocrinologists. Sales reps will also be addressing OB/GYNs, cardiologists and primary care physicians, and Takeda's payer group will be talking about the drug with insurers.
Sex Powder Avanafil / Stendra Sex Materials Powders CAS 330784-47-9
US $550-555 / Kilogram ( FOB Price)
1 Kilogram (Min. Order)
Place of Origin: CN;HUN ; CAS No.: 330784-47-9 ; Classification: High Purity Reagents ; Model Number: 330784-47-9 ; Purity: 99% min. ; Brand Name: yc ; Other Names: Avanafil ; MF: C23H26ClN7O3 ; Assay: 99% min.
View 1+ similar products
United States Contact Details
The billionaire investor described the Alibaba IPO as a “major landmark event” that is as significant as the Google IPO, and said Chinese internet companies will create "one global battlefield" with western companies over the next decade.
He warned that a lot of US and European companies are still denying the significance of Chinese internet companies, and that the Alibaba IPO will only make more people aware of the booming Chinese tech industry.
Pharmaceutical Export Company, You Can Buy Various High Quality Pharmaceutical Export Company Products from Global Pharmaceutical Export Company
Celldex Therapeutics, Inc.
Glembatumumab vedotin (CDX-011)
Auxilium Pharmaceuticals is launching an ad campaign for its ED drug Stendra which includes banner
Many things to come tomorrow including BIG BULLS as the TV ADVT announcements for 15 minutes action is out lined by Axill...
With this volume I can imagine how much Shorts must have struggled to keep this under control and prevent Pop up and triggers automatic orders for stop loss.
VVUS - Volume: 34,270,737 shares , AAPL Volume: 37,016,168
But VVUS has 115Million O/S shares and 77% Still under Institutional control ...whereas AAPL ....!!!!!!!!!
Its a data recording unit which is most desired after plane crashed. It's useful to investigate the cause of crash and people behind it- In case of OREX its a Short Sellers who are behind the crash after FDA approval, never mind 900 solders from Takeda taking this baby Contrave to the market next month. FBI expert ADAM FURESTEIN Predicted that Goldilocks (Physicians...) will drink only Baby bear( OREX) Porridge which is Contrave and not from Papa Bear (ARNA) or Mama Bear (VIVIUS).
Baba owner Ma will be the first in line to sell own shares (2/3) to stupid Americans at $68 without any financial transparency. Stupid Americans will line up leaving behind and short sell their own prime industry like Pharma / Biotech which still can rule the entire world.
A Logical Deal, But Not A Done Deal
Endo International announced after the close on Tuesday that it has made a bid to acquire Auxilium Pharmaceuticals for $2.2 billion with an equal mix of cash and stock. The bid, which was worth $28.10 for each Auxilium share at the time of the announcement, would give Auxilium shareholders a 31% premium to Tuesday's close but does come in short of the 52-week high ($32.89) and the all-time high set about six years ago when there was considerably greater optimism about Xiaflex.
ndo publicly announces its desire to acquire Auxilium for $28.10 per share.
Auxilium is currently playing it cool, but Endo's deal offers credible sales synergy, a chance to maximize the value of Xiaflex, and good cost and tax leverage for Endo.
Endo has room to up its bid, but the company's deal pipeline is reportedly pretty healthy and management likely won't overpay for Auxilium.
Viagra or Levitra need be taken ½ hour to one hour before expected intercourse, Cialis to be taken hours (or the day) before.............